Particle Image Velocimetry Investigation of Hemodynamics via Aortic Phantom
February 25th, 2022
4.8K views
The present protocol describes particle image velocimetry (PIV) measurements performed to investigate the sinus flow through the in vitro setup of the transcatheter aortic valve (TAV). The hemodynamic parameters based on velocity are also determined.
Overview
This protocol describes the use of particle image velocimetry (PIV) to measure velocity fields in the aortic sinus during transcatheter aortic valve implantation. It aims to provide insights into hemodynamic parameters that are crucial for understanding valvular blood flow.
Key Study Components
Area of Science
- Cardiovascular physiology
- Hemodynamics
- Medical device evaluation
Background
- Velocity information is critical for assessing blood flow through heart valves.
- Obtaining accurate velocity fields in vivo is challenging.
- This protocol allows for detailed hemodynamic analysis post-implantation.
- Understanding abnormal hemodynamics can lead to improved heart valve designs.
Purpose of Study
- To characterize hemodynamics after transcatheter aortic valve implantation.
- To facilitate the development of better prosthetic heart valves.
- To provide a reliable method for measuring velocity fields in an in vitro setup.
Methods Used
- Particle image velocimetry (PIV) for velocity measurement.
- In vitro setup mimicking aortic sinus conditions.
- Analysis of hemodynamic parameters based on velocity data.
- Comparison of results with in vivo studies.
Main Results
- Successful acquisition of instantaneous velocity fields.
- Detailed characterization of abnormal hemodynamics.
- Insights into the performance of prosthetic heart valves.
- Validation of PIV as a method for studying valvular blood flow.
Conclusions
- The protocol enhances understanding of hemodynamics in valve implantation.
- It provides a framework for future research on heart valve design.
- Further studies can build on the findings to improve patient outcomes.
Frequently Asked Questions
What is particle image velocimetry (PIV)?
PIV is an optical method used to measure velocity fields in fluid flows.
Why is velocity measurement important in cardiovascular research?
Velocity measurements help evaluate blood flow dynamics, which are crucial for understanding heart valve function.
How does this protocol improve upon existing methods?
It allows for accurate velocity field acquisition in an in vitro setting, which is difficult to achieve in vivo.
What are the potential applications of this research?
The findings can inform the design of better prosthetic heart valves and improve surgical outcomes.
Can this method be applied to other areas of cardiovascular research?
Yes, PIV can be adapted for various studies involving fluid dynamics in the cardiovascular system.
What challenges are associated with obtaining good particle images?
Challenges include ensuring proper lighting, particle seeding, and camera calibration for accurate measurements.
Executive Industry Relevance
High-resolution particle image velocimetry (PIV) enables precise quantification of hemodynamic parameters in aortic valve models, addressing critical gaps in understanding post-implantation flow dynamics. This capability supports mechanistic de-risking and predictive confidence for device design and target validation in cardiovascular R&D. Robust in vitro velocity field mapping informs early-stage portfolio decisions and cross-functional evaluation of prosthetic valve performance.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables detailed interrogation of flow-induced mechanisms underlying thrombus formation after valve implantation.
- Supports functional validation of device-target interactions by quantifying velocity, vorticity, and stasis zones.
- Facilitates predictive confidence in mechanistic hypotheses for device optimization.
Screening & Assay Development
- Provides standardized, reproducible in vitro models for evaluating hemodynamic impact of device variants.
- Generates quantitative velocity and particle residence data for comparative screening of design modifications.
- Supports assay readiness for downstream computational or experimental workflows.
Translational & Preclinical Research
- Aligns in vitro hemodynamic findings with disease-relevant flow conditions observed in clinical scenarios.
- Enables risk-adjusted advancement of device candidates based on translationally relevant flow metrics.
- Supports continuity from discovery through preclinical validation by providing robust, quantitative endpoints.
Pipeline & Workflow Integration
PIV-based hemodynamic analysis integrates into the discovery-to-preclinical continuum for cardiovascular device R&D, bridging early mechanistic studies and preclinical model validation.
- Discovery Biology: Quantifies flow fields to clarify mechanistic hypotheses and de-risk biological targets.
- Screening: Delivers reproducible, quantitative velocity and stasis outputs for comparative device evaluation.
- Analytics: Provides high-resolution velocity, vorticity, and particle residence measurements for robust statistical analysis.
- Translational Research: Aligns in vitro flow metrics with clinical hemodynamic endpoints for preclinical continuity.
- Enterprise Reuse: Establishes a reusable platform for iterative device assessment and cross-study standardization.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence and reduces mechanistic ambiguity in device-target interactions.
- Operational Value: Standardizes velocity field acquisition and analysis for scalable, reproducible workflows.
- Strategic Value: Informs go/no-go decisions and capital allocation by providing quantitative, risk-adjusted data.
- Portfolio Impact: Supports prioritization and advancement of device candidates based on robust hemodynamic evidence.
Implementation Considerations
- Requires expertise in PIV imaging, hemodynamics, and data analysis.
- Demands specialized instrumentation including high-speed cameras, lasers, and flow phantoms.
- Necessitates cross-team standardization of imaging protocols and data processing pipelines.
- Adaptation to other cardiovascular models may require protocol optimization and validation.
- Practical limitations include complexity of image acquisition and need for rigorous calibration.
Biopharma FAQs
Why does null hypothesis testing matter for velocity field analysis?
Null hypothesis testing in velocity field analysis enables objective evaluation of whether observed hemodynamic differences after valve implantation are statistically significant, supporting robust target validation and device optimization decisions.
How does independent variable isolation in PIV experiments support discovery?
Isolating variables such as valve size or flow rate in PIV experiments allows precise attribution of hemodynamic changes to specific device features, strengthening mechanistic insights and guiding early-stage design choices.
What do quantitative dependent variable measurements enable in hemodynamic studies?
Quantitative measurements of velocity, vorticity, and particle residence provide actionable data for comparing device variants, informing predictive models, and supporting cross-functional R&D collaboration.
Why are replication requirements critical for cross-functional hemodynamic analysis?
Replication ensures that velocity field and stasis measurements are reproducible across experiments, enabling reliable data sharing and decision-making among engineering, biology, and analytics teams.
What statistical analysis capabilities are needed before implementing PIV data in R&D?
Robust statistical tools are required to analyze velocity distributions, compare device conditions, and validate significance of observed hemodynamic effects prior to advancing device candidates in the pipeline.
